Back to search results
NCT06749132

Deep Learning-enhanced Personalized Monitoring of Aortic Stenosis - The DETECT-AS Prognostic Study

Enrolling by Invitation
Not specifiedAges 65+Observational
Yale University
~210 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Transthoracic echocardiogram

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Annualized change in AV Vmax in m/sec/years
Measured over From baseline TTE to TTE performed at enrollment

Conditions

Aortic Stenosis

Explore related trials

Aortic sclerosisAortic Valve Stenosis

Where it's being run

3 sites across 3 states
Connecticut1
New York1
Texas1

Study leadership

  • Rohan Khera, MD, MS · PRINCIPAL_INVESTIGATOR · Yale University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Annualized change in AV Vmax in m/sec/yearsFrom baseline TTE to TTE performed at enrollment

    The primary outcome measure is the annualized change in AV Vmax in m/sec/years, defined as the absolute difference between the value on the enrollment and baseline echocardiogram measurement, divided by the time difference between the studies.